Benitec Biopharma Inc. Common Stock (BNTC) is a publicly traded Healthcare sector company. As of May 21, 2026, BNTC trades at $10.99 with a market cap of $374.12M and a P/E ratio of -10.37. BNTC moved +2.99% today. Year to date, BNTC is -7.57%; over the trailing twelve months it is -21.11%. Its 52-week range spans $8.49 to $17.15. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces BNTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent BNTC insider activity includes SUVRETTA CAPITAL MANAGEMENT, LLC bought 65.80K, SUVRETTA CAPITAL MANAGEMENT, LLC bought 11.59K, SUVRETTA CAPITAL MANAGEMENT, LLC bought 14.32K, SUVRETTA CAPITAL MANAGEMENT, LLC bought 2.52K, and SUVRETTA CAPITAL MANAGEMENT, LLC bought 42.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $10.99 |
| Market Cap | $374.12M |
| P/E Ratio | -10.37 |
| EPS | $-1.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.15 |
| 52-Week Low | $8.49 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-37.92M |
| Gross Margin | 0.00% |
4 analysts cover BNTC: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.00.